Neurometabolite mapping highlights elevated myo-inositol profiles within the developing brain in down syndrome

The neurodevelopmental phenotype in Down Syndrome (DS), or Trisomy 21, is variable including a wide spectrum of cognitive impairment and a high risk of early-onset Alzheimer's disease (AD). A key metabolite of interest within the brain in DS is Myo-inositol (mIns). The NA+/mIns co-transporter i...

Descripción completa

Detalles Bibliográficos
Autores principales: Patkee, Prachi A., Baburamani, Ana A., Long, Katherine R., Dimitrova, Ralica, Ciarrusta, Judit, Allsop, Joanna, Hughes, Emer, Kangas, Johanna, McAlonan, Grainne M., Rutherford, Mary A., De Vita, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039898/
https://www.ncbi.nlm.nih.gov/pubmed/33711492
http://dx.doi.org/10.1016/j.nbd.2021.105316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039898/
https://www.ncbi.nlm.nih.gov/pubmed/33711492
http://dx.doi.org/10.1016/j.nbd.2021.105316

Ejemplares similares